Oral contraceptives, hormone replacement therapy, and stroke risk

T Johansson, P Fowler, WE Ek, A Skalkidou… - Stroke, 2022 - Am Heart Assoc
Background: Millions of women worldwide use exogenous hormones as oral contraceptives
or hormone replacement therapy. Still, time-dependent and long-term consequences of …

Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk

T Johansson, P Fowler, WE Ek, A Skalkidou… - Stroke, 2022 - diva-portal.org
BACKGROUND: Millions of women worldwide use exogenous hormones as oral
contraceptives or hormone replacement therapy. Still, time-dependent and long-term …

[HTML][HTML] Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk

T Johansson, P Fowler, WE Ek, A Skalkidou… - Stroke, 2022 - Am Heart Assoc
Background: Millions of women worldwide use exogenous hormones as oral contraceptives
or hormone replacement therapy. Still, time-dependent and long-term consequences of …

Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk

T Johansson, P Fowler, WE Ek, A Skalkidou… - Stroke, 2022 - ingentaconnect.com
Background: Millions of women worldwide use exogenous hormones as oral contraceptives
or hormone replacement therapy. Still, time-dependent and long-term consequences of …

Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk

T Johansson, P Fowler, WE Ek, A Skalkidou… - Stroke, 2022 - pubmed.ncbi.nlm.nih.gov
Background Millions of women worldwide use exogenous hormones as oral contraceptives
or hormone replacement therapy. Still, time-dependent and long-term consequences of …

Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk.

T Johansson, P Fowler, WE Ek, A Skalkidou… - Stroke, 2022 - europepmc.org
Background Millions of women worldwide use exogenous hormones as oral contraceptives
or hormone replacement therapy. Still, time-dependent and long-term consequences of …